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Abstract
A rare hereditary mechanobullous disorder called epidermolysis bullosa (EB) causes blister-
ing in the skin and the mucosal membranes. To date, nineteen EB-related genes have been
discovered in human and other species. We describe here a novel EB variant in dogs. Two
newborn littermates of Central Asian Shepherd dogs with severe signs of skin blistering
were brought to a veterinary clinic and euthanized due to poor prognosis. In post-mortem
examination, the puppies were shown to have findings in the skin and the mucosal mem-
branes characteristic of EB. A whole-genome sequencing of one of the affected puppies
was performed to identify the genetic cause. The resequencing data were filtered under a
recessive model against variants from 31 other dog genomes, revealing a homozygous
case-specific nonsense variant in one of the known EB-causing genes, COL7A1 (c.4579C>
T, p.R1527*). The variant results in a premature stop codon and likely absence of the func-
tional protein in the basement membrane of the skin in the affected dogs. This was con-
firmed by immunohistochemistry using a COL7A1 antibody. Additional screening of the
variant indicated full penetrance and breed specificity at ~28% carrier frequency. In sum-
mary, this study reveals a novel COL7A1 variant causing recessive dystrophic EB and pro-
vides a genetic test for the eradication of the disease from the breed.
Introduction
Epidermolysis bullosa (EB) belongs to a group of rare inherited skin conditions characterized
by development of blisters in the dermo-epidermal junction. EB is divided into several sub-
types based on structural changes in the skin, the mode of inheritance, and clinical, micro-
scopic and immunohistochemical findings (1). The four main types include EB simplex (EBS),
junctional EB (JEB), dystrophic EB (DEB) and Kindler syndrome (KS), which differ in their
phenotype and genotype; a common feature of all of them is the fragility of the skin and muco-
sae due to defects in the structural proteins of the basement membrane zone [1]. The level of







Citation: Niskanen J, Dillard K, Arumilli M, Salmela
E, Anttila M, Lohi H, et al. (2017) Nonsense variant
in COL7A1 causes recessive dystrophic
epidermolysis bullosa in Central Asian Shepherd
dogs. PLoS ONE 12(5): e0177527. https://doi.org/
10.1371/journal.pone.0177527
Editor: Florence Ruggiero, Ecole normale
superieure de Lyon, FRANCE
Received: December 13, 2016
Accepted: April 29, 2017
Published: May 11, 2017
Copyright: © 2017 Niskanen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The genome data is
freely available under accession no. PRJNA380744
(http://www.ebi.ac.uk/ena/data/view/
PRJNA380744) at the European Nucleotide
Archive.
Funding: This work was supported by the
Academy of Finland, grant number 1268091
(http://www.aka.fi/) (HL); the Jane and Aatos Erkko
Foundation (http://jaes.fi/) (HL); Biocentrum
Helsinki (http://www.helsinki.fi/biocentrum/) (HL);
the Orion Research Foundation (http://www.orion.
cleavage between the dermis and the epidermis varies by the subtype, and is located in the
basal or suprabasal cell layer in EBS, in the lamina lucida in JEB or below the lamina densa in
DEB [2]. Multiple levels of cleavage within basal keratinocytes, lamina lucida or sublamina
densa region are found in the KS [2]. EB is clinically highly heterogeneous with subtype-spe-
cific symptoms but distinguishing features include blisters and skin erosions, milia, nail
defects, granulation tissue, keratoderma and dyspigmentation [1]. The disease onset varies
between birth and early infancy [1].
A wide range of genetic causes for EB have been identified, reflecting the heterogeneous
clinical picture. The list of nineteen known recessive or dominant EB genes include COL7A1,
COL17A1,DSP, DST, EXPH5, FERMT1, ITGA3, ITGA6, ITGB4, JUP, KLHL24,KRT5, KRT14,
LAMA3, LAMB3, LAMC2, PLEC, PKP1 and TGM5 [3,4]. To date, defects in four of them have
been linked to different types of canine EB: a premature stop codon in PKP1 causing ectoder-
mal dysplasia-skin fragility syndrome [5], a nonsense mutation in PLEC causing EBS [6], an
insertion in LAMA3 causing JEB [7] and a missense mutation in COL7A1 causing a mild form
of DEB [8]. Additional EB cases with unknown molecular background have been described in
German Shorthaired Pointers and mixed-breed dogs with JEB as well as in Akita Inu with
DEB [9]. We describe here a novel recessive and severe form of dystrophic EB in Central
Asian Shepherd (CAS) dogs with a nonsense variant in COL7A1.
Results
Histological analysis reveals typical features of EB
Two CAS dogs from a litter of eight puppies were brought to a veterinary clinic soon after
birth due to severe skin lesions, blisters and ulcers on feet, ears, muzzle and oral mucosa. Epi-
dermolysis bullosa was suspected and the affected dogs were euthanized due to a poor progno-
sis and sent for necropsy.
Both puppies had multiple vesicles, bullae and ulcers in the oral and oropharyngeal mucosa,
inner pinnae, dorsal plane of the nose, ventral abdomen, external genitalia, metacarpal and
metatarsal skin and footpads (Fig 1). Histologically, there was separation at the dermal-epider-
mal junction with cleft formation. Small and large vacuoles were detected at the basement
membrane (Fig 2A and 2B). Some of the large vacuoles were confluent, resulting in a split at
the basement membrane. PAS-positive material, suggestive of basement membrane, was
found on the roof and/or floor in the bullae and strands crossing the bullae were seen in the
larger clefts (Fig 2C). The larger clefts included numerous mononuclear cells, neutrophils,
necrotic debris and erythrocytes denoting secondary inflammation. No specific macroscopic
or histological changes were present in the brain, the respiratory and gastrointestinal tract,
heart, liver, spleen, pancreas, kidneys, thyroid and adrenal glands and gonads.
COL7A1 truncation confirms dystrophic EB
EB is inherited either in a recessive or dominant manner. A recessive mode of inheritance was
suspected in the CAS pedigree as the two severely affected CAS dogs were born to healthy
parents (Fig 3). The whole genome of one affected puppy was sequenced with an average cov-
erage of 13X. Altogether 6 880 938 variants were called, of which 2 776 951 were homozygous.
The variants were filtered against whole-genome data from 31 other dogs (Table 1) under
recessive model. This decreased the number of homozygous coding variants to 401 and only
one of them was found in the known EB genes, a nonsense variant at chr20:40,532,043 in the
COL7A1 gene (c.4579C>T, p.R1527) (Fig 4). This variant results in a premature stop codon
in the 45th exon (p.R1527) and a predicted early truncation of COL7A1 (Fig 4).
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The identified COL7A1 variant was selected as a prime candidate for EB in the CAS dogs
for three reasons. First, COL7A1 defects are known to cause recessive dystrophic EB in human
and animals [9,10]. Second, the identified homozygous nonsense variant is predicted to result
in the severe truncation of the COL7A1 protein, which very likely renders it non-functional.
Finally, none of the other genes with coding variants are known to cause EB in any species and
appeared therefore unlikely to be causal. To understand the penetrance, prevalence and speci-
ficity of the mutation, we genotyped the identified COL7A1 variant in the second affected dog,
the unaffected littermates, the parents, and additional 37 non-EB CAS dogs available in our
Fig 1. The macroscopic changes of epidermolysis bullosa in the affected puppy. (A) Large erupted blisters were present on the nasal plane, lips and
dorsal skin of the front paws. (B) Large intact and erupted blisters were also present in the inner ear lobe. (C) Numerous intact bullae were found on the
digital pads and the erupted blisters of metacarpal and carpal pads resulted in the formation of large ulcers.
https://doi.org/10.1371/journal.pone.0177527.g001
Fig 2. Histological stainings of the haired skin of the inner ear lobe by periodic acid–Schiff (PAS). (A) Small vacuoles at the basement membrane
(arrowheads) (63X). (B) Larger, confluent vacuoles result in a split along the basement membrane zone (arrowheads) (63X). (C) Large subepidermal cleft
with PAS-positive material, suggestive of basement membrane, on the roof and floor of the cleft and strands crossing the bulla (arrows) (20X). Epidermis is
denoted with “E” and dermis with “D”.
https://doi.org/10.1371/journal.pone.0177527.g002
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biobank. The second affected dog was also homozygous for the nonsense variant while the
parents and the unaffected littermates were carriers, indicating a complete segregation of the
mutation with the disease. The mutation was absent in 143 dogs from related breeds (Table 2),
and found only in the CAS breed at 27.7% carrier frequency.
To study the effect of the truncation mutation on the expression of COL7A1, we performed
immunohistochemical staining in the skin samples of the affected puppies and age-matched
controls using a COL7A1 antibody. In the control skin, a strong linear positive collagen VII
Fig 3. A pedigree of the affected puppies with a suspected recessive mode of inheritance. The COL7A1 variant genotype is denoted for individuals
that were tested. White symbol denotes wild type (C/C), half-filled heterozygous carrier (C/T) and black symbol homozygous mutant (T/T), while grey
denotes that no sample was available for testing. The whole genome was sequenced from the affected dog surrounded with a square.
https://doi.org/10.1371/journal.pone.0177527.g003
Table 1. Summary of the unaffected control dogs used in the whole-genome variant filtering study.




Karelian Bear Dog 1
Leonberger 1
White Shepherd Dog 1
Dandie Dinmont Terrier 1
Swedish Vallhund 1
Welsh Springer Spaniel 1
https://doi.org/10.1371/journal.pone.0177527.t001
COL7A1 defect in canine dystrophic epidermolysis bullosa
PLOS ONE | https://doi.org/10.1371/journal.pone.0177527 May 11, 2017 4 / 10
staining was detected in the basement membrane zone of the epidermis (Fig 5A). In the
affected puppies, the basement membrane zone was completely negative for collagen VII (Fig
5B). These results demonstrate the absence of functional COL7A1 in the affected dogs.
Fig 4. Chromatograms of the COL7A1 c.4579C>T variant and a schematic representation of the collagen VII protein. (A) Three genotypes are
present in the Central Asian Shepherd Dog cohort: wild type C/C, heterozygous carrier C/T and homozygous mutant T/T. The mutation causes a
change from arginine (CGA) to a stop codon (TGA). (B) The domain structure of collagen VII. The substitution site p.R1527* is located near the
beginning of the characteristic triple-helical domain. (C) A schematic presentation of the dimerization of collagen VII homotrimers. If the abnormal
COL7A1 is translated the p.R1527* substitution results in severe truncation of the protein, preventing the dimerization of collagen VII at the C-terminal
end.
https://doi.org/10.1371/journal.pone.0177527.g004
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Discussion
We discovered a novel pathological COL7A1 variant that results in a premature stop codon and
subsequently causes recessive dystrophic epidermolysis bullosa (RDEB) in the CAS breed. RDEB
is a subtype of EB that is characterized by generalized blistering and scarring of the skin as well
as extracutaneous complications, such as failure to thrive, multifactorial anemia, pseudosyndac-
tyly and esophageal strictures [1,11]. The clinical symptoms of the two affected CAS dogs were
very similar to those of human RDEB, especially in terms of the severity, the onset at birth, failure
to thrive, and the extent of the skin lesions. The macroscopic and histological changes in the skin
were also typical of EB. In human dystrophic EB patients, over 300 COL7A1mutations have
been found, and they include nonsense, missense, deletion, insertion, insertion-deletion, splice-
site and regulatory mutations [10]. Generally, the type and position of the mutation correlates
with the severity of the phenotype, and premature stop codons in the triple-helical domain often
have serious effects [10].
In the case of the CAS dogs, the premature stop codon in COL7A1 results in the absence of
functional COL7A1. It is possible that the abnormal transcript either undergoes nonsense-
mediated decay or, if stable enough to be translated, produces a severely truncated COL7A1
protein, which in turn is unstable, or fails to be deposited at the dermal-epidermal junction.
The lack of COL7A1 expression was confirmed by IHC staining in the skin of the affected
dogs. During maturation, three COL7A1 subunits are assembled into collagen VII homotri-
mers, the NC2 domain in the C-terminus is proteolytically processed, and two homotrimers
Table 2. Summary of study cohorts used in the COL7A1 c.4579C>T variant screening.
Breed Number of dogs Number of carriers
Central Asian Shepherd Dog 47 13
Caucasian Shepherd Dog 39 0
South Russian Ovcharka 3 0
Kuvasz 6 0
Slovakian Chuvach 19 0
Tibetan Mastiff 76 0
https://doi.org/10.1371/journal.pone.0177527.t002
Fig 5. Immunohistochemical staining for collagen VII. (A) The basement membrane zone between the
epidermis and dermis is positive for collagen VII in the haired skin of the flank of an unaffected control. (100X)
(B) The basement membrane zone between the intact epidermis and dermis and the roof and floor of the
vacuoles during early cleft formation are negative for collagen VII in the haired skin of the inner ear lobe of an
affected puppy (100X). Epidermis is denoted with “E” and dermis with “D”.
https://doi.org/10.1371/journal.pone.0177527.g005
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are linked from their C-terminal ends with disulfide bonds to form dimers [12]. The possi-
ble truncated COL7A1 would lack C-terminal ends, which are required to link the dimers,
and therefore the assembly of the anchoring fibrils would be compromised in the affected
dogs.
The CAS disease represents a severe form of RDEB, consistent with the nonsense COL7A1
variant. Another canine RDEB model has been previously described in Golden Retrievers with
a missense mutation in COL7A1 (c.5761G>A, p.G1906S) [8,13]. The affected dogs were
reported to suffer from a mild form of the disorder, however, a more detailed description was
not provided for comparison with the CAS dogs.
No cure for EB exists. Multiple treatments have been studied, including gene, recombinant
protein and cell therapies, gene editing and induced pluripotent stem cells (iPSC) [14–21].
Regarding RDEB specifically, the goal of gene therapy would be to restore the collagen VII
function in epithelial tissues. The Golden Retriever RDEB model has been utilized to study
cell therapy, such as the clinical effects of ex vivo corrected keratinocyte grafts [8,22]. The
severity of EB in the CAS dogs challenges their utilization in intervention studies, and there-
fore, the major impact of our gene discovery is that it enables an efficient identification of




Sample collection in Finland was ethically approved by the Animal Ethics Committee of State
Provincial Office of Southern Finland (ESAVI/7482/04.10.07/2015). All samples were collected
from privately owned dogs by owner’s consent.
Study cohort
A CAS litter of eight puppies was born at term. Two puppies (male and female) were eutha-
nized at owner’s request soon after birth due to severe lesions in the haired skin and oral
mucosa, and the affected puppies were taken to necropsy. The puppies were euthanized by a
veterinarian, and the euthanization consisted of intramuscular sedation followed by adminis-
tration of a lethal overdose of intravenous anesthetic. During necropsy, a liver sample was
collected and frozen for later DNA isolation. EDTA blood was collected from the healthy litter-
mates, parents and other unaffected dogs from the breed. The samples were stored at -20˚C.
Genomic DNA was extracted using the semi-automated Chemagen extraction robot (Perki-
nElmer ChemagenTechnologie GmbH). DNA concentration was determined either with
NanoDrop ND-1000 UV/Vis Spectrophotometer or Qubit 3.0 Fluorometer (Thermo Fisher
Scientific Inc). Pedigree data were obtained from the public databases of the Finnish Kennel
Club (http://jalostus.kennelliitto.fi/) and the Estonian Kennel Club (http://register.kennelliit.
ee/). The pedigree was constructed with the AncesTrim software [23] and rendered with Gen-
oPro (http://www.genopro.com/).
Necropsy
A full necropsy was performed on both puppies. Tissue samples of the skin, oral mucosa, inter-
nal organs and brain were collected for histological examination. The tissue samples were for-
malin fixed, routinely processed, paraffin embedded, sectioned at 4 μm thickness and stained
with hematoxylin and eosin (HE). Skin samples were also stained with the periodic acid–Schiff
(PAS) stain to delineate the zone of separation at the dermo-epidermal junction. Healthy
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control skin samples for IHC staining were collected at necropsy from two puppies of different
breeds that had died due to other diseases.
Whole-genome sequencing
We performed whole-genome sequencing on one affected Central Asian Shepherd dog. A
fragment library with a median insert size of 400 bp was prepared and sequenced on Illumina
HiSeq2500 to generate paired-end reads of 2125 bp. Mapping, variant calling and subsequent
data analysis was performed as previously described in Hyto¨nen et al. 2016 [24].
Genomic DNA analysis
Cohorts of 47 Central Asian Shepherd dogs and several related breeds, including 39 Caucasian
Shepherd Dogs, 76 Tibetan Mastiffs, 3 South Russian Ovcharkas, 6 Kuvasz and 19 Slovakian
Chuvach, were genotyped for the COL7A1 c.4579C>T variant. Genotyping of the variant was
performed by standard PCR with the following primers: 5’-CTCTGCTCTTCTTCCCCAGG-3’
and 5’-CCTCCCTCTGCTTACCACTG-3’. The amplified PCR products were sequenced with
a capillary sequencer and the sequence data were analyzed using Sequencher 5.1 (GeneCodes).
Immunohistochemistry
The skin samples of two affected puppies were sectioned at 4 μm thickness and deparaffinized.
Antigen retrieval was done with Proteinase K for 5 minutes at 37˚C. The primary collagen VII
antibody (Monoclonal Anti-Collagen, Type VII Antibody, clone LH7.2, SAB4200686, Sigma-
Aldrich, USA) was incubated for two hours at 37˚C with a dilution of 1:50. The tissue sections
were stained with UltraVision LP Detection System HRP polymer and AEC chromogen kit
(Thermo Fischer Scientific Inc., USA). The staining was performed according to the protocol
of the kit without the hydrogen peroxide block step. Skin samples collected at necropsy from
two 0 to 2-day-old puppies with normal skin were used as controls.
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